These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 27607919

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
    Ranawaka RR, Nagahawatte A, Gunasekara TA.
    Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Persistent fingernail onychomycosis caused by Fusarium proliferatum in a healthy woman.
    Brasch J, Shimanovich I.
    Mycoses; 2012 Jan; 55(1):86-9. PubMed ID: 21668519
    [No Abstract] [Full Text] [Related]

  • 8. Topical treatment of onychomycosis with efinaconazole solution 10%.
    Rich P.
    Cutis; 2013 Jun; 91(6):305-7. PubMed ID: 23837154
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Onychomycosis caused by Fusarium proliferatum.
    Hattori N, Shirai A, Sugiura Y, Li W, Yokoyama K, Misawa Y, Okuzumi K, Tamaki K.
    Br J Dermatol; 2005 Sep; 153(3):647-9. PubMed ID: 16120158
    [Abstract] [Full Text] [Related]

  • 13. [Onychomycosis is rare in young children, and treatment is a task for dermatological specialists].
    Haugaard LK, Skov L, Arendrup MC, Saunte DM.
    Ugeskr Laeger; 2013 Sep 30; 175(40):2343-4. PubMed ID: 24079324
    [Abstract] [Full Text] [Related]

  • 14. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
    Cook-Bolden FE, Lin T.
    Cutis; 2017 Apr 30; 99(4):286-289. PubMed ID: 28492600
    [Abstract] [Full Text] [Related]

  • 15. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA.
    J Am Podiatr Med Assoc; 2014 Nov 30; 104(6):568-73. PubMed ID: 25514267
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.
    Ranawaka RR, de Silva SH.
    Int J Dermatol; 2017 Feb 30; 56(2):202-208. PubMed ID: 27813064
    [Abstract] [Full Text] [Related]

  • 17. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine.
    Elewski BE.
    Arch Dermatol; 1997 Oct 30; 133(10):1317-8. PubMed ID: 9382581
    [No Abstract] [Full Text] [Related]

  • 18. Case of Fusarium paronychia successfully treated with occlusive dressing of antifungal cream.
    Ikeda I, Ohno T, Ohno H, Miyazaki Y, Nishimoto K, Fukushima S, Makino T, Ihn H.
    J Dermatol; 2014 Apr 30; 41(4):340-2. PubMed ID: 24533442
    [Abstract] [Full Text] [Related]

  • 19. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC, Joseph WS.
    J Drugs Dermatol; 2014 Oct 30; 13(10):1186-90. PubMed ID: 25607552
    [Abstract] [Full Text] [Related]

  • 20. Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients.
    Galletti J, Negri M, Grassi FL, Kioshima-Cotica ÉS, Svidzinski TI.
    Eur J Clin Microbiol Infect Dis; 2015 Sep 30; 34(9):1767-72. PubMed ID: 26007318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.